logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
13/08/2025
US Treasury Secretary Mnuchin: "The Federal Reserve has fundamental issues."
Latest
2 m ago
The US tariff revenue soared to $28 billion in July, but it was unable to prevent the monthly deficit from approaching $300 billion.
4 m ago
CITIC Construction Investment: Margin trading balance surpasses 2 trillion, operating in a healthy and active state
4 m ago
CITIC Securities: Domestic robots are blooming, we continue to be optimistic about the overall sector's market situation.
7 m ago
Non-standard trusts are expected to fully implement diversified investment strategies, and the single financing model is about to come to an end.
8 m ago
The weight loss drug of Eli Lilly and Company performed disappointingly in a key trial, after which the company's CEO, David Ricks, and other insiders bought a total of nearly $3 million worth of stock in subsequent stock sales. Eli Lilly's CEO, David Ricks, purchased $1 million worth of the company's stock on Tuesday. Following disappointing trial data for Eli Lilly's weight loss drug and a subsequent drop in stock price, several executives and board members of Eli Lilly saw an opportunity to buy. According to documents submitted to the Securities and Exchange Commission, five insiders at Eli Lilly collectively purchased $2.9 million worth of stock in the past few days. These insiders include Eli Lilly's CEO, David Ricks, who purchased slightly over $1 million worth of stock on Tuesday.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.